Geoffrey M. Nichol's most recent trade in Tempest Therapeutics Inc was a trade of 16,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 13, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Tempest Therapeutics Inc | Geoffrey M. Nichol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
Tempest Therapeutics Inc | Geoffrey M. Nichol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 8,200 | 8,200 | - | - | Stock Option (right to buy) | |
Tempest Therapeutics Inc | Geoffrey M. Nichol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 3,500 | 3,500 | - | - | Stock Option (Right to Buy) | |
Tempest Therapeutics Inc | Geoffrey M. Nichol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 6,635 | 6,635 | - | - | Stock Option (Right to Buy) |